DNMT3a in the hippocampal CA1 is crucial in the acquisition of morphine self-administration in rats

Jian Jun Zhang, Feng Ze Jiang, Wei Zheng, Ying Duan, Shu Bo Jin, Fang Shen, Jing Liang, Ming Li, Nan Sui

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Drug-reinforced excessive operant responding is one fundamental feature of long-lasting addiction-like behaviors and relapse in animals. However, the transcriptional regulatory mechanisms responsible for the persistent drug-specific (not natural rewards) operant behavior are not entirely clear. In this study, we demonstrate a key role for one of the de novo DNA methyltransferase, DNMT3a, in the acquisition of morphine self-administration (SA) in rats. The expression of DNMT3a in the hippocampal CA1 region but not in the nucleus accumbens shell was significantly up-regulated after 1- and 7-day morphine SA (0.3 mg/kg/infusion) but not after the yoked morphine injection. On the other hand, saccharin SA did not affect the expression of DNMT3a or DNMT3b. DNMT inhibitor 5-aza-2-deoxycytidine (5-aza) microinjected into the hippocampal CA1 significantly attenuated the acquisition of morphine SA. Knockdown of DNMT3a also impaired the ability to acquire the morphine SA. Overall, these findings suggest that DNMT3a in the hippocampus plays an important role in the acquisition of morphine SA and may be a valid target to prevent the development of morphine addiction.

Original languageEnglish (US)
JournalAddiction Biology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Self Administration
Morphine
decitabine
Morphine Dependence
Hippocampal CA1 Region
Saccharin
Aptitude
Nucleus Accumbens
Methyltransferases
Reward
Pharmaceutical Preparations
Hippocampus
Recurrence
Injections
DNA

Keywords

  • DNMT3a
  • acquisition
  • hippocampal CA1
  • morphine
  • self-administration

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology
  • Psychiatry and Mental health

Cite this

DNMT3a in the hippocampal CA1 is crucial in the acquisition of morphine self-administration in rats. / Zhang, Jian Jun; Jiang, Feng Ze; Zheng, Wei; Duan, Ying; Jin, Shu Bo; Shen, Fang; Liang, Jing; Li, Ming; Sui, Nan.

In: Addiction Biology, 01.01.2019.

Research output: Contribution to journalArticle

Zhang, Jian Jun ; Jiang, Feng Ze ; Zheng, Wei ; Duan, Ying ; Jin, Shu Bo ; Shen, Fang ; Liang, Jing ; Li, Ming ; Sui, Nan. / DNMT3a in the hippocampal CA1 is crucial in the acquisition of morphine self-administration in rats. In: Addiction Biology. 2019.
@article{19175dea829f4e0a9f6965a47bd60ccc,
title = "DNMT3a in the hippocampal CA1 is crucial in the acquisition of morphine self-administration in rats",
abstract = "Drug-reinforced excessive operant responding is one fundamental feature of long-lasting addiction-like behaviors and relapse in animals. However, the transcriptional regulatory mechanisms responsible for the persistent drug-specific (not natural rewards) operant behavior are not entirely clear. In this study, we demonstrate a key role for one of the de novo DNA methyltransferase, DNMT3a, in the acquisition of morphine self-administration (SA) in rats. The expression of DNMT3a in the hippocampal CA1 region but not in the nucleus accumbens shell was significantly up-regulated after 1- and 7-day morphine SA (0.3 mg/kg/infusion) but not after the yoked morphine injection. On the other hand, saccharin SA did not affect the expression of DNMT3a or DNMT3b. DNMT inhibitor 5-aza-2-deoxycytidine (5-aza) microinjected into the hippocampal CA1 significantly attenuated the acquisition of morphine SA. Knockdown of DNMT3a also impaired the ability to acquire the morphine SA. Overall, these findings suggest that DNMT3a in the hippocampus plays an important role in the acquisition of morphine SA and may be a valid target to prevent the development of morphine addiction.",
keywords = "DNMT3a, acquisition, hippocampal CA1, morphine, self-administration",
author = "Zhang, {Jian Jun} and Jiang, {Feng Ze} and Wei Zheng and Ying Duan and Jin, {Shu Bo} and Fang Shen and Jing Liang and Ming Li and Nan Sui",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/adb.12730",
language = "English (US)",
journal = "Addiction Biology",
issn = "1355-6215",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - DNMT3a in the hippocampal CA1 is crucial in the acquisition of morphine self-administration in rats

AU - Zhang, Jian Jun

AU - Jiang, Feng Ze

AU - Zheng, Wei

AU - Duan, Ying

AU - Jin, Shu Bo

AU - Shen, Fang

AU - Liang, Jing

AU - Li, Ming

AU - Sui, Nan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Drug-reinforced excessive operant responding is one fundamental feature of long-lasting addiction-like behaviors and relapse in animals. However, the transcriptional regulatory mechanisms responsible for the persistent drug-specific (not natural rewards) operant behavior are not entirely clear. In this study, we demonstrate a key role for one of the de novo DNA methyltransferase, DNMT3a, in the acquisition of morphine self-administration (SA) in rats. The expression of DNMT3a in the hippocampal CA1 region but not in the nucleus accumbens shell was significantly up-regulated after 1- and 7-day morphine SA (0.3 mg/kg/infusion) but not after the yoked morphine injection. On the other hand, saccharin SA did not affect the expression of DNMT3a or DNMT3b. DNMT inhibitor 5-aza-2-deoxycytidine (5-aza) microinjected into the hippocampal CA1 significantly attenuated the acquisition of morphine SA. Knockdown of DNMT3a also impaired the ability to acquire the morphine SA. Overall, these findings suggest that DNMT3a in the hippocampus plays an important role in the acquisition of morphine SA and may be a valid target to prevent the development of morphine addiction.

AB - Drug-reinforced excessive operant responding is one fundamental feature of long-lasting addiction-like behaviors and relapse in animals. However, the transcriptional regulatory mechanisms responsible for the persistent drug-specific (not natural rewards) operant behavior are not entirely clear. In this study, we demonstrate a key role for one of the de novo DNA methyltransferase, DNMT3a, in the acquisition of morphine self-administration (SA) in rats. The expression of DNMT3a in the hippocampal CA1 region but not in the nucleus accumbens shell was significantly up-regulated after 1- and 7-day morphine SA (0.3 mg/kg/infusion) but not after the yoked morphine injection. On the other hand, saccharin SA did not affect the expression of DNMT3a or DNMT3b. DNMT inhibitor 5-aza-2-deoxycytidine (5-aza) microinjected into the hippocampal CA1 significantly attenuated the acquisition of morphine SA. Knockdown of DNMT3a also impaired the ability to acquire the morphine SA. Overall, these findings suggest that DNMT3a in the hippocampus plays an important role in the acquisition of morphine SA and may be a valid target to prevent the development of morphine addiction.

KW - DNMT3a

KW - acquisition

KW - hippocampal CA1

KW - morphine

KW - self-administration

UR - http://www.scopus.com/inward/record.url?scp=85063914962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063914962&partnerID=8YFLogxK

U2 - 10.1111/adb.12730

DO - 10.1111/adb.12730

M3 - Article

C2 - 30950138

AN - SCOPUS:85063914962

JO - Addiction Biology

JF - Addiction Biology

SN - 1355-6215

ER -